| Structure | Chemical Name | CAS | MF |
|
CEV protocol
|
|
|
|
|
CEV14 protein
|
|
|
|
|
CFL1 protein
|
|
|
|
|
CEV regimen
|
|
|
|
|
(C)FLSKMLVYDPAKRISGKMALKHPYFDDLDNQIKKM
|
|
|
|
CFM1571hydrochloride
|
268725-86-6
|
C23H28N4O3
|
|
C-[3-(4-Fluoro-phenyl)-isoxazol-5-yl]-methylaminehydrochloride
|
|
C10H10ClFN2O
|
|
C-(2-Fluoro-phenyl)-C-phenyl-methylaminehydrochloride
|
293726-41-7
|
C13H13ClFN
|
|
C-[1-(4-Fluoro-benzyl)-piperidin-4-yl]-methylamine hydrochloride
|
|
C13H20ClFN2
|
|
C-[1-(4-Fluoro-benzyl)-piperidin-3-yl]-methylamine hydrochloride
|
|
C13H20ClFN2
|
|
C-[1-(3-Fluoro-benzyl)-piperidin-4-yl]-methylamine hydrochloride
|
|
C13H20ClFN2
|
|
C-[1-(2-Fluoro-benzyl)-piperidin-3-yl]-methylamine hydrochloride
|
|
C13H20ClFN2
|
|
C-[1-(3-Fluoro-benzyl)-piperidin-3-yl]-methylamine hydrochloride
|
|
C13H20ClFN2
|
|
C-[1-(4-Fluoro-benzenesulfonyl)-piperidin-3-yl]-MethylaMine hydrochloride
|
|
C12H18ClFN2O2S
|
|
C-[1-(4-Fluoro-benzenesulfonyl)-piperidin-4-yl]-MethylaMine hydrochloride
|
1215609-88-3
|
C12H18ClFN2O2S
|
|
C-(5-Fluoro-6-Methoxy-pyridin-3-yl)-MethylaMine
|
1211532-92-1
|
C7H9FN2O
|
|
C-(5-Fluoro-2-Methoxy-pyridin-3-yl)-MethylaMine
|
|
C7H9FN2O
|
|
C-[1-(4-Fluoro-phenyl)-cyclopentyl]-methylamine
|
75180-50-6
|
C12H16FN
|
|
C-[1-(4-Fluoro-phenyl)-cyclopropyl]-methylamine
|
75180-46-0
|
C10H12FN
|
|
C-(4-Fluoro-phenyl)-C-phenyl-methylamine hydrochloride
|
451503-41-6
|
C13H12FN.ClH
|
|
C-(5-Fluoro-3-methyl-pyridin-2-yl)-methylamine
|
886365-60-2
|
C7H9FN2
|
|
C-[4-(3-Fluoro-benzyl)-morpholin-2-yl]-methylamine dihydrochloride
|
407640-28-2
|
C12H19Cl2FN2O
|
|
C-[2-(4-Fluoro-phenyl)-oxazol-4-yl]-methylamine
|
885272-89-9
|
C10H9FN2O
|
|
C-[1-(2-Fluoro-phenyl)-cyclopropyl]-methylamine
|
886365-63-5
|
C10H12FN
|
|
|
C8-18 Fluoroalcohol phosphate
|
|
|
|
C-[2-(4-Fluoro-phenyl)-imidazo[1,2-a]pyridin-3-yl]-methylamine
|
|
C14H12FN3
|
|
4-[(4-Fluorophenyl)methyl]-2-morpholinemethanamine
|
112914-13-3
|
C12H17FN2O
|
|
|
C9-13 Fluoroalcohol
|
|
|
|
C-(5-Fluoro-1H-benzimidazol-2-yl)-methylamine
|
|
C8H8FN3
|
|
|
C9-15 Fluoroalcohol phosphate
|
|
|
|
C-[3-(2-Fluoro-phenyl)-isoxazol-5-yl]-methylamine
|
543713-33-3
|
C10H9FN2O
|
|
C-[4-(2-Fluoro-phenyl)-tetrahydro-pyran-4-yl]-methylamine
|
889939-78-0
|
C12H16FNO
|
|
C-[8-(4-Fluoro-phenyl)-1,4-dioxa-spiro[4.5]dec-8-yl]-methylamine
|
|
C15H20FNO2
|
|
C-(3-Fluoro-5-trifluoromethyl-pyridin-2-yl)-methylamine
|
|
C7H6F4N2
|
|
C-[4-(2-Fluoro-benzyl)-morpholin-2-yl]-methylamine dihydrochloride
|
|
C12H19Cl2FN2O
|
|
C-(4'-Fluoro-biphenyl-4-yl)-methylamine hydrochloride
|
518357-40-9
|
C13H13ClFN
|
|
C-(4-Fluoro-phenyl)-C-(1-methyl-1H-imidazol-2-yl)-methylamine
|
872107-78-3
|
C11H12FN3
|
|
C-(5-Fluoro-pyrazolo[1,5-a]pyridin-2-yl)-methylamine
|
|
C8H8FN3
|
|
C-(3'-Fluoro-biphenyl-4-yl)-methylamine hydrochloride
|
893649-06-4
|
C13H12FN
|
|
C-[1-(3-Fluoro-phenyl)-cyclopropyl]-methylamine
|
886365-90-8
|
C10H12FN
|
|
C-[2-(4-Fluoro-phenyl)-thiazol-4-yl]-methylamine
|
885280-17-1
|
C10H9FN2S
|
|
|
C-(4-Fluoro-phenyl)-C-pyridin-4-yl-methylamine dihydrochloride
|
|
|
|
C-[1-(3-Fluoro-phenyl)-cyclopentyl]-methylamine
|
|
C12H16FN
|
|
C-[1-(4-Fluoro-phenyl)-3,5-dimethyl-1H-pyrazol-4-yl]-methylamine
|
|
C12H14FN3
|
|
C-[1-(2-Fluoro-phenyl)-cyclopentyl]-methylamine
|
|
C12H16FN
|
|
C-(2'-Fluoro-biphenyl-4-yl)-methylamine hydrochloride
|
893649-05-3
|
C13H12FN
|
|
C-[4-(4-Fluoro-phenyl)-tetrahydro-pyran-4-yl]-methylamine
|
|
C12H16FNO
|
|
C-[2-(4-Fluoro-phenyl)-benzo[d]imidazo[2,1-b]thiazol-3-yl]-methylamine
|
522651-98-5
|
C16H12FN3S
|
|
|
C-(4-Fluoro-phenyl)-C-pyridin-3-yl-methylamine dihydrochloride
|
|
|
|
C-[2-(3-Fluoro-phenyl)-thiazol-4-yl]-methylamine
|
885280-31-9
|
C10H9FN2S
|
|
|
CexCBD CbhI protein
|
|
|
|
|
CfMNPV gp67 protein
|
|
|
|
|
CFMPV protocol
|
|
|
|
|
Cgctcgagcgg, 5'-non-phosphorylated
|
|
|
|
|
5' CGCTCTAGAACTAGTGGATC 3'
|
|
|
|
|
Cgctcgagcgg, 5'-phosphorylated
|
|
|
|
C-6-G-d3 hydrate-trifluoroacetate
|
|
C26H29D3F3NO12
|
|
|
CgCYC1 protein
|
|
|
|
|
CEX protein
|
|
|
|
CFP10 (71-85)
|
646997-09-3
|
C72H120N24O25
|
|
|
CFO I
|
81811-52-1
|
|
|
|
C-276 foil, 0.2mm (0.008in) thick
|
|
|
|
|
β-CG-ELA kit
|
|
|
|
|
C-160 FN 100 UL P/S SYRINGE
|
|
|
|
|
CfpA protein
|
|
|
|
|
CFP - Cyan Fluorescent Protein:Cyan Fluorescent Protein
|
|
|
|
CEYQAGHNKVGSLQY
|
|
C73H109N21O24S
|
|
|
CEZF protein
|
|
|
|
|
CGG
|
|
|
|
|
C-fos
|
1849687-41-7
|
|
|
|
C-FOS ANTISENSE OLIGO
|
|
|
|
|
C-FOS CONTROL OLIGO
|
|
|
|
|
c-Fos (Fos)
|
|
|
|
|
c-fos, Human, Recombinant, Sf9 insect cells
|
|
|
|
|
C-FOS-INDUCED GROWTH FACTOR (FIGF)
|
|
|
|
|
C-fos(i mmediate early gene, ieg)
|
|
|
|
|
c-fos IHC System
|
|
|
|
|
c-fos(IHC dilution: 1:100)
|
|
|
|
|
C-fos(IHC dilution: Ready-to-use)
|
|
|
|
|
c-Fos, NT (Fos)
|
|
|
|
|
c-fos (Oncogene Protein), Clone: NCL-FOS, Mab anti-, NO paraffin
|
|
|
|
|
c-fos Oncoprotein (BSA & Azide Free)
|
|
|
|
|
c-fos Oncoprotein (Fos)
|
|
|
|
|
c-fos (Oncogene Protein), 62kD, Clone: CF1, Mab anti-Human, frozen/paraffin
|
|
|
|
C-FOS PEPTIDE-2
|
|
C60H88N18O24S
|
|
C-FOS PEPTIDE-1
|
|
C126H221N45O41S
|
|
|
c-fos Peptide
|
|
|
|
|
c-Fos, phosphorylated (Ser374) (Fos)
|
|
|
|
|
C-FOS PRIMER
|
|
|
|
|
C-FOS TRANSCRIPTION FACTO
|
|
|
|
|
Cggaattccg, 5'-phosphorylated
|
|
|
|
|
Cggaattccg, 5'-non-phosphorylated
|
|
|
|
|
Cggactagtccg, 5'-non-phosphorylated
|
|
|
|
|
Cggactagtccg, 5'-phosphorylated
|
|
|
|
|
5' CGGATTTCCTTGAAGAGAGTA 3'
|
|
|
|
|
Cggatatccg, 5'-phosphorylated
|
|
|
|
|
Cggatatccg, 5'-non-phosphorylated
|
|
|
|
|
Cggcatgccg, 5'-phosphorylated
|
|
|
|
|
Cggcagctgccg, 5'-non-phosphorylated
|
|
|
|
|
Cggcatgccg, 5'-non-phosphorylated
|
|
|